Phase I/Ib study of the SERD LSZ102 alone or in combination with ribociclib in ER+ breast cancer Meeting Abstract


Authors: Juric, D.; Curigliano, G.; Cresta, S.; Yap, Y. S.; Terret, C.; Duhoux, F. P.; Takahashi, S.; Kundamal, N.; Bhansali, S.; Liao, S.; Crystal, A.; Jhaveri, K.
Abstract Title: Phase I/Ib study of the SERD LSZ102 alone or in combination with ribociclib in ER+ breast cancer
Meeting Title: 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017)
Journal Title: Cancer Research
Volume: 78
Issue: 4 Suppl.
Meeting Dates: 2017 Dec 5-9
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000425489402039
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS17-P5-21-04
Notes: Meeting Abstract: P5-21-04 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Komal Lachhman Jhaveri
    201 Jhaveri